or
Remember me
Back
October 20, 2021 - Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF)
Reliable, quick, contactless, cost-effective screening solutions to bring safety to your workplace.
Mitigate risks to your team and to the uninterrupted operation of your business by setting up Safe Entry Stations for infectious disease symptom detection or for impairment detection. Our screening products are quick, noninvasive, no-contact solutions that can detect indication of symptoms.
All it takes is a simple walk-through.
WATCH GLOBAL NEWS STORY
“Implementing Safe Entry at our plants has dramatically decreased our absenteeism and increased employee peace of mind. Keeping our staff safe is top priority, and as such, we were determined to implement the best available solution, which we found in Safe Entry.”
- Nicholas Reichenbach, Founder & Executive Chairman, Flow Water Inc.
Designed by infectious disease experts, medical doctors, impairment specialists, and a global team of data scientists, and using a vast collection of continually updated real-world data, Predictmedix’s patent-pending screening is entirely autonomous and designed to protect the privacy of the end-user.
“The most interesting part is that Predictmedix focuses on AI solutions to problems that matter to all of us.”
- Kapil Raval, Advisor at Predictmedix, Director of Artificial Intelligence Business Development, Microsoft
Safe Entry Stations are currently operating at many companies and events around the world.
Completely unique to other solutions on the market, Predictmedix’s leading technology is changing the way we look at mass screening for infectious diseases and impairment. Safe Entry’s autonomous, comprehensive analysis provides peace of mind to individuals and businesses wherever people are entering shared spaces, be it for work or entertainment.
READ THE LATEST NEWS
Learn how the Safe Entry Station comprehensively screens without any contact.
Watch video of SAFE ENTRY STATION
DOWNLOAD PDF PRESENTATION
Predictmedix (CSE:PMED) (OTCQB:PMEDF) is an emerging provider of rapid health screening and remote patient care solutions globally. The Company’s Safe Entry Stations – powered by a proprietary artificial intelligence (AI) – use multispectral cameras to analyze physiological data patterns and predict a variety of health issues. The Company’s current product is able to screen for infectious diseases such as COVID-19, while its technology under development will screen for impairment by drugs or alcohol, or various mental illnesses. Predictmedix’s proprietary remote patient care platform under development will empower medical professionals with a suite of AI-powered tools to improve patient health outcomes. To learn more, please visit our website at www.Predictmedix.com or follow us on Twitter, Instagram or LinkedIn.
For further information please contact:
Investor Relations
MZ Group – MZ North America Phone: 949-259-4987 Email: PMEDF@mzgroup.us Visit www.mzgroup.us
VISIT PREDICTMEDIX INC.
Subscribe to Stockwatch Articles
Read Recent Issues of Stockwatch Articles
A daily snapshot of everything from market open to close.